| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | 3 | 1 | 2 | 11 | — | — | — | — | — | 9 | 1 |
| total | individual payouts | |
|---|---|---|
| 2029 | ‡‡‡‡‡ |
|
| 2028 | ‡‡‡‡ |
|
| 2027 | ‡‡‡‡‡ |
|
| 2026 | 7.32 |
—
—
—
|
| 2025 | 7.03 |
—
—
—
—
|
| 2024 | 6.37 |
—
—
—
—
|
| 2023 | 5.77 |
—
—
—
—
|
| 2022 | 5.02 |
—
—
—
—
|
| 2021 | 3.97 |
—
—
—
—
|
| 2020 | 3.52 |
—
—
—
—
|
| 2019 | 3.40 |
—
—
—
—
|
| 2018 | 2.94 |
—
—
—
—
|
| 2017 | 2.64 |
—
—
—
—
|
| 2016 | 2.52 |
—
—
—
—
|
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Cash | 475.18 | 422.00 | 467.00 | 501.00 |
| Receivables | 2,827.30 | 2,866.00 | 2,910.00 | 3,170.00 |
| Inventory | 2,907.88 | 2,787.00 | 2,839.00 | 3,166.00 |
| Other | 183.00 | 140.00 | 153.00 | 200.00 |
| 6,834.23 | 6,799.00 | 6,950.00 | 7,695.00 |
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Payables | 2,050.93 | 1,992.00 | 2,126.00 | 2,439.00 |
| ST’ Debt | 3,814.00 | — | — | — |
| Other | 1,496.00 | — | 1,315.00 | 1,245.00 |
| 7,735.37 | 7,313.00 | 5,819.00 | 6,096.00 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Sep | Dec | Mar | Jun | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’26 | 5,084.00 | 5,174.00 | 5,486.00 | 5,755.00 |
21,499.00
|
| ’25 | 4,904.00 | 4,743.00 | 4,960.00 | 5,243.00 |
19,850.00
|
| ’24 | 4,847.49 | 4,820.95 | 5,074.36 | 5,187.21 |
19,930.00
|
| ’23 | 4,232.78 | 4,674.81 | 5,061.67 | 5,095.75 |
19,065.00
|
| ’22 | 3,762.81 | 3,824.58 | 4,086.39 | 4,187.83 |
15,861.61
|
| ’21 | 3,230.54 | 3,411.91 | 3,746.33 | 3,958.87 |
14,347.64
|
| Sep | Dec | Mar | Jun | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’26 | 782.00 | 862.00 | 984.00 | 1,736.00 |
4,364.00
|
| ’25 | 744.00 | 935.00 | 630.00 | 1,467.00 |
3,776.00
|
| ’24 | 649.96 | 702.03 | 795.09 | 1,236.92 |
3,384.00
|
| ’23 | 457.36 | 618.78 | 718.76 | 1,185.11 |
2,980.00
|
| ’22 | 424.36 | 581.11 | 542.97 | 893.29 |
2,441.73
|
| ’21 | 737.37 | 616.61 | 527.42 | 693.60 |
2,575.00
|
| Sep | Dec | Mar | Jun | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’26 | 699.00 | 794.00 | 886.00 | 1,566.00 |
3,945.00
|
| ’25 | 662.00 | 814.00 | 561.00 | 1,336.00 |
3,373.00
|
| ’24 | 552.92 | 596.31 | 723.42 | 1,120.35 |
2,993.00
|
| ’23 | 384.91 | 517.15 | 632.05 | 1,077.89 |
2,612.00
|
| ’22 | 383.91 | 538.35 | 496.64 | 832.15 |
2,251.04
|
| ’21 | 701.85 | 683.66 | 492.57 | 627.55 |
2,505.63
|
| Sep | Dec | Mar | Jun | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’26 | 6.29 | 6.60 | 7.06 | 8.54 |
28.48
|
| ’25 | 5.34 | 7.25 | 7.37 | 7.16 |
27.12
|
| ’24 | 4.99 | 5.23 | 5.56 | 6.01 |
21.84
|
| ’23 | 2.98 | 3.04 | 4.54 | 5.44 |
16.04
|
| ’22 | 3.45 | 2.97 | 2.67 | 0.99 |
10.09
|
| ’21 | 2.47 | 3.41 | 3.59 | 3.84 |
13.35
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | 230.44 | 288.61 | 449.39 | 488.45 | 815.01 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 340.00 | 464.00 | 712.42 | 908.35 | 1,099.94 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 55,090 | 62,730 | 61,120 | 57,950 | 59,850 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.29 | 0.30 | 0.33 | 0.34 | 0.36 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 15,861.61 | 19,065.00 | 19,930.00 | 19,850.00 | 21,499.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 33.49% | 33.72% | 35.77% | 36.85% | 37.69% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,614.23 | 2,680.00 | 3,595.00 | 4,107.00 | 4,563.00 | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | 10.18% | 14.06% | 18.04% | 20.69% | 21.22% | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,316.19 | 2,084.00 | 2,845.00 | 3,532.00 | 3,649.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 571.76 | 818.00 | 927.00 | 907.00 | 937.00 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 123.40 | 148.48 | 155.10 | 154.72 | 170.22 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | 10.24 | 16.23 | 22.13 | 27.52 | 28.89 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 19.00 | 23.21 | 26.33 | 29.43 | 34.55 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1.48) | (2.87) | (3.04) | (3.14) | (3.32) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 17.51 | 20.34 | 23.29 | 26.29 | 31.24 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 68.93 | 80.52 | 94.02 | 106.71 | 122.03 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 128.54 | 128.40 | 128.50 | 128.30 | 126.30 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 24.05 | 24.03 | 22.64 | 25.37 | 33.85 | ‡‡‡‡ | ‡‡‡‡ | — |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.99 | 2.63 | 3.23 | 4.51 | 5.75 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.57 | 4.84 | 5.33 | 6.55 | 8.02 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.68 | 3.26 | 3.75 | 5.05 | 6.20 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 18.92 | 23.82 | 24.96 | 29.72 | 33.81 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2,441.73 | 2,980.00 | 3,384.00 | 3,776.00 | 4,364.00 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (190.69) | (368.00) | (391.00) | (403.00) | (419.00) | ‡‡‡‡‡ | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2,251.04 | 2,612.00 | 2,993.00 | 3,373.00 | 3,945.00 | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6,187.32 | (901.14) | (514.00) | 1,131.00 | 1,599.00 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 11,515.83 | 12,610.28 | 7,157.00 | 7,494.00 | 6,766.00 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 10,952.16 | 12,135.10 | 6,735.00 | 7,027.00 | 6,265.00 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8,859.92 | 10,338.28 | 12,081.00 | 13,691.00 | 15,413.00 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5.68% | 7.45% | 9.60% | 12.01% | 12.09% | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8.86% | 8.55% | 12.67% | 12.25% | 13.36% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 15.23% | 21.70% | 25.37% | 27.40% | 25.07% | — | — | — |
ROE
|
Parker-Hannifin Corporation (PH) exemplifies resilient growth in motion and control technologies, masterfully riding industrial cycles, aerospace recoveries, and trends in electrification and automation. Strategic moves like the $8.3 billion Meggitt acquisition in 2022 have diversified its high-margin aerospace exposure, driving revenue from $11.4 billion in 2016 to $19.9 billion in 2024—a 7.3% CAGR outpacing peers. Operational efficiency shines with revenue per employee up 40% to $326,000, gross margins expanding from 22.3% to 35.8%, and EBT margins nearly doubling to 18%, fueled by pricing power, premium products, and aftermarket strength amid Boeing and Airbus ramps.
PH’s profitability powerhouse delivers ROE projected at 27.4% for 2025, free cash flow per share tripling to $26.29, and aggressive debt reduction to a manageable 2x EBITDA. Stock performance mirrors these fundamentals, with shares quadrupling post-pandemic lows and trading at a fair 22-25x forward PE, backed by analyst targets implying 5-14% upside. Insider sells appear as routine profit-taking after a 40%+ YTD surge, not red flags.
Looking ahead, PH is poised for acceleration with revenue forecasted to $24.1 billion by 2028 and EPS climbing 26% to $33.90, propelled by aerospace aftermarkets, EV filtration, and factory automation. In a fragmented market ripe for M&A, PH’s compounding book value and innovation edge signal multi-year upside—read the full analysis for the data-driven case in this industrial juggernaut.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.